Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML. (Q40330454): Difference between revisions

From Wikidata
Jump to navigation Jump to search
Daniel Mietchen (talk | contribs)
Amasuela (talk | contribs)
Changed Asturian description: artículu científicu espublizáu en 2006, batch #62927
 
(5 intermediate revisions by 2 users not shown)
description / astdescription / ast
artículu científicu
artículu científicu espublizáu en 2006
description / hydescription / hy
 
2006 թվականի հունվարի 12-ին հրատարակված գիտական հոդված
Property / author name string
Susanne Schnittger
 
Property / author name string: Susanne Schnittger / rank
Normal rank
 
Property / author name string: Susanne Schnittger / qualifier
 
Property / author name string: Susanne Schnittger / reference
stated in: Europe PubMed Central
PubMed publication ID: 16410449
retrieved: 19 September 2017
Timestamp+2017-09-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 
Property / author: Susanne Schnittger / qualifier
 
Property / author: Susanne Schnittger / qualifier
 
object named as: Susanne Schnittger
Property / author: Susanne Schnittger / reference
 
stated in: Europe PubMed Central
PubMed publication ID: 16410449
retrieved: 19 September 2017
Timestamp+2017-09-19T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Latest revision as of 01:19, 30 August 2021

scientific article published on 12 January 2006
Language Label Description Also known as
English
Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML.
scientific article published on 12 January 2006

    Statements

    Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML. (English)

    Identifiers